全球切片檢查鉗和息肉切除勒除器市場：市場規模、佔有率和趨勢分析（2026-2032 年）

預計到2025年，全球切片檢查鉗和息肉切除勒除器市場規模約為4.72億美元。預計到2032年，該市場將以2.3%的複合年成長率成長，達到5.53億美元以上。

本報告涵蓋切片檢查鉗和息肉切除勒除器，它們用於胃腸內視鏡檢查中的組織取樣和息肉切除術。報告量化了銷售量、平均售價 (ASP)、市場價值、成長率和企業市場占有率。此外，報告還分析了市場促進因素、限制因素、近期併購活動和技術趨勢。報告提供了 2022 年至 2024 年的歷史數據以及至 2032 年的預測數據。

這份研究報告反映了一次性器械的日益普及、結直腸癌篩檢計劃的擴大以及手術程序向冷勒除器轉變，正在如何塑造全球切片檢查鉗和息肉切除勒除器市場。

市場概覽

切片檢查鉗和息肉切除勒除器是胃腸內視鏡檢查中最常用的附件之一，在診斷和切除胃腸道病變、息肉和異常組織方面發揮著至關重要的作用。

過去十年，受技術進步、監管政策更新和全球健康趨勢的推動，該市場發生了顯著變化。儘管銷售量大幅成長，但由於醫院和門診內視鏡中心紛紛採用經濟實惠的一次性產品，價格競爭仍面臨壓力。

幾年前價格大幅下跌後，切片檢查鉗市場銷售強勁反彈。一次性器械價格親民，刺激了使用量的成長，從而支撐了市場規模，但也降低了製造商的利潤率。到了2025年，價格下跌趨勢趨於平緩，更穩定的定價環境帶來持續的收入成長。

同時，息肉切除勒除器部分也受益於臨床上越來越偏好使用冷勒除器切除小息肉，這一趨勢正在增強對勒除器的需求，尤其是在全球結直腸癌篩檢計畫擴大的情況下。

隨著手術量的增加、器械使用模式向一次性使用模式轉變，以及培訓水準的提高使全球醫生更容易掌握先進的息肉切除技術，複雜的市場格局仍在不斷演變。儘管價格競爭和可重複使用器械普及率的下降抑制了整體市場成長，但預計到2032年，該市場將保持溫和、持續的成長。

市場促進因素

拋棄式鑷子

拋棄式切片檢查鉗已成為大多數醫療機構的首選。先前價格大幅下降後，拋棄式活體組織切片鉗在醫院和診所越來越常見。其低廉的價格促使其在全球範圍內的使用量和銷量不斷成長。

儘管價格下跌擠壓了製造商的淨利率，但手術量的成長仍然是總收入的主要推動力。預計未來幾年價格只會小幅下降，因此銷量仍將是市場成長的主要動力。此外，某些地區限制使用可重複使用器械的法規和感染控制措施也推動了拋棄式的穩定普及。

由於製造商專注於提高設計可靠性和最先進的鉗口機制，拋棄式鉗市場預計將繼續主導全球切片檢查鉗市場。

增加大腸直腸癌篩檢

大腸鏡檢查仍然是全球最常見的內視鏡檢查之一。截至2025年，全球範圍內促進大腸直腸癌早期發現的努力已顯著擴大，尤其是在北美、歐洲和亞太部分地區。

篩檢項目的參與度提高直接增加了切片檢查和息肉切除術的數量，從而推高了對活體組織切片鉗和勒除器的需求。許多已開發地區的人口老化進一步加劇了這一趨勢，因為老年人是結直腸癌的高風險族群。

隨著持續進行的意識提升宣傳活動以及將篩檢納入國家健康指南，大腸直腸癌預防已成為一項重要的公共衛生優先事項。因此，預計在預測期內，對切片檢查鉗和息肉切除勒除器等內視鏡器械的需求將持續成長。

冷勒除器技術

從歷史上看，8 毫米或更小的息肉都是用切片檢查鉗切除的，但冷圈套術（使用非電勒除器切除小息肉，勒除器清除效果更好）正在成為許多診所的標準治療方法。

這項技術降低了黏膜熱損傷的風險，提高了切除的徹底性，並縮短了手術時間。隨著其應用範圍的擴大，息肉切除的需求預計將穩定成長。

手術流程的這種轉變是市場成長的關鍵促進因素，因為它擴大了勒除器的應用範圍，不僅用於處理較大的病灶，也用於處理較小、更常見的病例。製造商們正在積極回應，設計出操控性更好、鋼絲更細、形狀記憶性能更強的產品，以提高手術精度。

市場限制

從鑷子到勒除器的轉變

冷勒除器在小型息肉切除術中的廣泛應用對市場而言是一把雙面刃。雖然它促進了勒除器的需求，但也導致某些適應症下切片檢查鉗的使用量下降。隨著醫生越來越傾向於使用勒除器進行完整切除，活體組織切片鉗在這些小型息肉病例中的使用率持續下降。

這種趨勢在臨床指引推薦使用冷勒除器而非切片檢查切除小型息肉的國家尤為明顯。預計從長遠來看，這種轉變將抑制切片檢查鉗領域的成長潛力。

技術課題

儘管勒除器具有臨床優勢，但其操作難度高於鉗取息肉。位於腸壁附近的扁平或無蒂息肉難以捕獲，且切除息肉的成功回收率也參差不齊。這凸顯了持續培訓和改進勒除器設計的必要性。

雖然經驗豐富的內視鏡醫師可以克服這些課題，但它們仍然是該手術更廣泛採用的限制因素，尤其是在工作人員經驗不足的中心。

可重複使用設備減少

可重複使用切片檢查鉗的市場持續快速萎縮。這些器械比一次性器械價格更高，且若處理不當，有交叉感染的風險。多個地區的監管措施正在加速這一轉變。例如，英國已實施相關法規，禁止在臨床環境中使用可重複使用的活體組織切片鉗。

這種轉變抑制了整體市場價值，因為可重複使用器械的單位銷售更高。目前，一次性器械佔市場主導地位，但由於其價格分佈較低，儘管銷量成長，但整體市場成長卻受到限制。

目標市場和數據範圍

定量範圍

市場規模、佔有率和預測

成長率、銷售量、平均售價

定性數據

市場成長趨勢與限制因素

競爭對手分析與SWOT分析

併購、公司簡介、產品系列

美國食品藥物管理局召回事件與顛覆性技術發展

影響需求的疾病和手術數據概述

時期

• 基準年：2025年
• 預測：2026-2032年
• 歷史資料：2022-2024年

數據來源

此外，也參考了內視鏡醫師、產業專家和市場主管的初步訪談、醫院採購資料、進出口資料庫和 iData Research 內部資料庫。

方法

收入預測模型為銷售量乘以平均售價，並根據區域手術量、利用模式和更換週期檢驗。

目標市場及區隔

• 切片檢查鉗和息肉切除勒除器市場進一步區隔如下：

切片檢查鉗

息肉切除

競爭分析

波士頓科學公司是市場領導，預計到2025年將佔全球切片檢查鉗和息肉切除勒除器市場近一半的佔有率。該公司的成功主要歸功於其Radial Jaw產品線的強大實力，該產品線是全球應用最廣泛的活體組織切片鉗系列之一。波士頓科學公司透過持續投資產品創新和建立全球分銷網路，鞏固了其在多個地區的領先地位。

奧林巴斯公司憑藉其可重複使用的切片檢查鉗和勒除器產品組合保持著一定的市場佔有率。然而，隨著市場對可重複使用切片檢查鉗的需求持續下降，奧林巴斯近年來市佔率逐漸下滑。在歐洲和部分亞洲國家等仍偏好可重複使用器械的市場，奧林巴斯仍保持著較強的競爭力。

庫克醫療是全球市場第三大競爭對手。該公司提供全系列產品，包括Captura Pro活體組織切片鉗、Captura一次性熱活體組織切片鉗和Captura迷你活體組織切片鉗。在勒除器領域，庫克醫療銷售AcuSnare息肉切除圈套器和AcuSnare鴨嘴圈套器，這兩款產品以其能夠捕獲小型、難以切除的息肉而聞名。

總體而言，市場集中度較低，這三家製造商佔了全球銷售額的大部分。規模較小的區域性公司主要在本地市場競爭，通常專注於價格具競爭力的消耗品。

科技與臨床趨勢

目前，在感染預防政策和降低再處理成本的推動下，使用拋棄式切片檢查鉗已成為全球主流做法。

由於安全性和邊緣清除能力的提高，冷勒除器正逐漸取代熱勒除器和鑷子來切除小型息肉。

一次性儀器的設計品質不斷提高，其性能可與可重複使用的儀器相媲美，而成本卻低得多。

引入了符合人體工學的手柄和改進的鉗口幾何形狀，以提高精度並減少長時間手術過程中操作者的疲勞。

隨著內視鏡學會推廣安全切除術和冷勒除器技術，世界各地都在努力規範訓練和操作流程。

有利於一次性用品和感染控制合規性的監管政策轉變，持續影響醫院和診所的採購決策。

地區

本期內容涵蓋全球市場，包括來自北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的數據。

調查方法附錄與簡稱

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

切片檢查鉗和息肉切除勒除器市場

• 摘要整理
  • 全球切片檢查鉗和息肉切除勒除器市場概覽
  • 競爭分析
  • 流程分段
  • 市場區隔
  • 目標區域
• 介紹
• 手術次數
  • 全組織切片檢查程序
  • 切片檢查技術
  • 息肉切除勒除器手術
• 市場概覽
  • 按區隔市場
  • 按地區
• 市場分析與預測
  • 全切片檢查鉗和息肉切除勒除器市場
  • 切片檢查鉗市場
  • 息肉切除勒除器市場
• 推動和阻礙因素
• 競爭市佔率分析

簡稱

The global biopsy forceps and polypectomy snare market was valued at approximately $472 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 2.3%, reaching over $553 million by 2032.

This report covers biopsy forceps and polypectomy snares used in gastrointestinal endoscopy for tissue sampling and polyp removal. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, recent mergers and acquisitions, and technology trends. It provides historical data from 2022 to 2024 and forecasts to 2032.

The scope reflects how the increasing adoption of disposable devices, the expansion of colorectal cancer screening programs, and procedural shifts toward cold snaring are shaping the global biopsy forceps and polypectomy snare markets.

Market Overview

Biopsy forceps and polypectomy snares are among the most frequently used accessories in gastrointestinal endoscopy. They play an essential role in diagnosing and removing lesions, polyps, and abnormal tissue from the digestive tract.

Over the past decade, this market has experienced notable changes driven by technological evolution, regulatory updates, and global health trends. While unit volumes have expanded significantly, pricing dynamics have remained under pressure as hospitals and ambulatory endoscopy centers adopt cost-effective single-use products.

Following a sharp drop in pricing several years ago, the biopsy forceps segment saw a strong rebound in unit sales. The affordability of disposable devices encouraged more frequent use, which in turn supported total market value despite reduced margins for manufacturers. By 2025, price erosion had slowed, and a more stable pricing environment allowed for steady revenue growth.

In parallel, the polypectomy snare segment has benefited from increasing clinical preference for cold snaring in small polyp removal procedures. This trend has strengthened demand for snares, especially as global colorectal cancer screening programs expand.

The combined market continues to evolve as procedure volumes grow, device usage patterns shift toward single-use models, and training improvements make advanced polypectomy techniques more accessible to physicians worldwide. While competitive pricing and declining reusable device adoption constrain overall value growth, the market remains poised for moderate and sustained expansion through 2032.

Market Drivers

Disposable Forcep

Disposable biopsy forceps have become the preferred choice in most healthcare settings. After the steep price drop seen in earlier years, disposable forceps became much more accessible to hospitals and clinics. The lower cost continues to encourage frequent use, increasing unit volumes worldwide.

Although reduced pricing has narrowed manufacturer margins, total revenues are still rising as procedure volumes increase. With only modest price declines projected over the coming years, unit sales will remain the main contributor to market expansion. This steady shift toward disposables has also been supported by regulatory and infection-control measures discouraging reusable device use in certain regions.

As manufacturers focus on improving design reliability and cutting-edge jaw mechanisms, the disposable segment is expected to strengthen its dominance within the global biopsy forceps market.

Increase in Colorectal Cancer Screening

Colonoscopy remains one of the highest-volume endoscopic procedures worldwide. As of 2025, global initiatives promoting early detection of colorectal cancer have expanded significantly, particularly in North America, Europe, and parts of Asia-Pacific.

Rising participation in screening programs is directly increasing the number of biopsy and polypectomy procedures, thereby boosting demand for both forceps and snares. The aging population in many developed regions is further driving this trend, as older adults represent the highest-risk group for colorectal cancer.

Ongoing awareness campaigns and the inclusion of screening in national health guidelines have made colorectal cancer prevention a key public health priority. As a result, the need for endoscopic tools such as biopsy forceps and polypectomy snares will continue to grow over the forecast period.

Cold Snaring Technique

Historically, small polyps under 8 millimeters were removed using biopsy forceps. However, the cold snaring technique, which uses a non-electrified snare to excise small polyps with better margin clearance, is becoming the standard of care in many practices.

The technique reduces the risk of thermal injury to the mucosa, improves completeness of resection, and shortens procedure time. As adoption increases, demand for polypectomy snares is expected to rise steadily.

This procedural shift represents a key driver for market growth, as it expands snare utilization beyond larger lesions into smaller, more common cases. Manufacturers are responding with product designs that offer better control, thinner wires, and improved shape memory for enhanced precision.

Market Limiters

Shift from Forceps to Snaring

The widespread adoption of cold snaring for small polyps is a double-edged factor for the market. While it benefits snare demand, it has also contributed to a decline in biopsy forceps usage for certain indications. As physicians increasingly favor snares for complete resections, forceps utilization in these smaller cases continues to fall.

This trend is particularly evident in countries where clinical guidelines recommend cold snaring over biopsy for small polyp removal. The shift is expected to constrain the growth potential of the biopsy forceps segment over time.

Technical Challenges

Despite its clinical benefits, snaring presents higher technical difficulty compared to forceps use. Flat or sessile polyps that lie close to the intestinal wall are harder to capture, and successful retrieval of resected polyps can be inconsistent. Studies have reported retrieval failure rates near 16 percent, which underscores the need for continued training and refinement of snare designs.

While experienced endoscopists can overcome these challenges, they remain a limiting factor for broader procedural adoption, particularly in facilities with less experienced staff.

Decline in Reusable Devices

The market for reusable biopsy forceps continues to decline rapidly. These instruments are more expensive than disposable versions and carry risks of cross-contamination if reprocessed improperly. Regulatory measures in several regions have accelerated this transition. For example, the United Kingdom has implemented restrictions that prohibit the use of reusable forceps in clinical settings.

This shift has constrained overall market value, as reusable devices contribute higher revenue per unit. Although disposables now dominate the market, their lower price points limit total market growth despite higher volumes.

Market Coverage and Data Scope

Quantitative Coverage

Market size, shares, and forecasts

Growth rates, units sold, and average selling prices

Qualitative Coverage

Market growth trends and limiters

Competitive analysis and SWOT for top competitors

Mergers and acquisitions, company profiles, and product portfolios

FDA recalls and disruptive technology developments

Disease overview and procedure data influencing demand

Time Frame

• Base year: 2025
• Forecasts: 2026-2032
• Historical data: 2022-2024

Data Sources

Primary interviews with endoscopists, industry experts, and market executives, supplemented by hospital procurement data, import and export databases, and iData Research's internal database.

Method Note

Revenue estimates are modeled from units multiplied by ASP, validated against procedure numbers, utilization patterns, and replacement cycles by region.

Markets Covered and Segmentation

• Biopsy Forceps & Polypectomy Snare Market - Further Segmented Into:

Biopsy Forceps

Polypectomy Snares

Competitive Analysis

Boston Scientific was the market leader in 2025, holding nearly half of the global biopsy forceps and polypectomy snare market. The company's success is largely attributed to the strength of its Radial Jaw product line, which remains one of the most widely used forceps families globally. Boston Scientific's consistent investment in product innovation and global distribution has solidified its leadership position across multiple regions.

Olympus Corporation maintained its presence through a portfolio of reusable biopsy forceps and snares. However, as demand for reusables continues to decline, Olympus has experienced gradual share erosion in recent years. The company remains most competitive in markets where reusable devices are still preferred, such as select European and Asian countries.

Cook Medical ranked as the third-largest competitor in the global market. The company offers a comprehensive product range that includes Captura Pro Biopsy Forceps, Captura Disposable Hot Biopsy Forceps, and Captura Mini Biopsy Forceps. Within the snare segment, Cook markets the AcuSnare Polypectomy Snare and its AcuSnare Duck Bill variant, known for their performance in capturing small and difficult polyps.

Overall, the market remains moderately consolidated, with these three manufacturers controlling the majority of global revenue. Smaller regional firms compete primarily in localized markets, often focusing on cost-competitive disposable offerings.

Technology and Practice Trends

The shift toward disposable biopsy forceps is now the dominant global trend, driven by infection prevention policies and lower reprocessing costs.

Cold snaring is replacing hot snaring and forceps resection for smaller polyps due to improved safety and margin clearance.

Single-use designs continue to improve in quality, offering comparable performance to reusable instruments at a fraction of the cost.

Ergonomic handles and improved jaw geometry are being introduced to enhance precision and reduce operator fatigue during extended procedures.

Training and procedural standardization efforts are increasing worldwide as endoscopy societies promote safe polypectomy and cold snare techniques.

Regulatory shifts in favor of disposables and infection control compliance continue to drive purchasing decisions in hospitals and clinics.

Geography

This edition provides complete global coverage, including data for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global biopsy forceps and polypectomy snare market

How are pricing trends and disposable adoption shaping revenue growth across regions

What are the key risks and challenges, including declining reusable device sales and price competition

How will colorectal cancer screening programs influence demand for forceps and snares over the next decade

Which manufacturers are leading, and how are they positioning their product portfolios to compete globally

What technological and procedural shifts are redefining physician preferences in biopsy and polypectomy

The Global Biopsy Forceps & Polypectomy Snares Market Report from iData Research answers these questions with procedure-aware models, company share data, and price trend analysis. Use it to evaluate opportunities, benchmark performance, and plan product strategies in one of the most essential accessory markets in gastrointestinal endoscopy.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Biopsy Forceps And Polypectomy Snares Market

• 8.1 Executive Summary
  • 8.1.1 Global Biopsy Forceps & Polypectomy Snares Market Overview
  • 8.1.2 Competitive Analysis
  • 8.1.3 Procedure Segmentation
  • 8.1.4 Market Segmentation
  • 8.1.5 Regions Included
• 8.2 Introduction
• 8.3 Procedure Numbers
  • 8.3.1 Total Tissue Biopsy Procedures
  • 8.3.2 Biopsy Forceps Procedures
  • 8.3.3 Polypectomy Snare Procedures
• 8.4 Market Overview
  • 8.4.1 By Segment
  • 8.4.2 By Region
• 8.5 Market Analysis And Forecast
  • 8.5.1 Total Biopsy Forceps And Polypectomy Snares Market
  • 8.5.2 Biopsy Forceps Market
  • 8.5.3 Polypectomy Snare Market
• 8.6 Drivers And Limiters
  • 8.6.1 Market Drivers
  • 8.6.2 Market Limiters
• 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Biopsy Forceps & Polypectomy Snares Market, Global, 2025 & 2032
• Chart 8-2: Biopsy Forceps & Polypectomy Snares Procedures, Global, 2025
• Chart 8-3: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Chart 8-4: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Chart 8-5: Biopsy Forceps & Polypectomy Snares Market by Segment, Global, 2022 - 2032
• Chart 8-6: Biopsy Forceps and Polypectomy Snares Market by Region, Global, 2022 - 2032
• Chart 8-7: Leading Competitors, Biopsy Forceps & Polypectomy Snares Market, Global, 2025

LIST OF FIGURES

• Figure 8-1: Biopsy Forceps & Polypectomy Snares Procedure Segmentation
• Figure 8-2: Biopsy Forceps & Polypectomy Snares Market Segmentation
• Figure 8-3: Biopsy Forceps & Polypectomy Snares Regions Covered, Global (1 of 2)
• Figure 8-4: Biopsy Forceps & Polypectomy Snares Regions Covered, Global (2 of 2)
• Figure 8-5: Tissue Biopsy Procedures by Segment, Global, 2022 - 2032
• Figure 8-6: Tissue Biopsy Procedures by Region, Global, 2022 - 2032
• Figure 8-7: Tissue Biopsy Procedures by Country, North America, 2022 - 2032
• Figure 8-8: Tissue Biopsy Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-9: Tissue Biopsy Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-10: Tissue Biopsy Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-11: Tissue Biopsy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-12: Tissue Biopsy Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-13: Tissue Biopsy Procedures by Country, Middle East, 2022 - 2032
• Figure 8-14: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-15: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-16: Tissue Biopsy Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-17: Tissue Biopsy Procedures by Country, Africa, 2022 - 2032
• Figure 8-18: Biopsy Forceps Procedures by Region, Global, 2022 - 2032
• Figure 8-19: Biopsy Forceps Procedures by Country, North America, 2022 - 2032
• Figure 8-20: Biopsy Forceps Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-21: Biopsy Forceps Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-22: Biopsy Forceps Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-23: Biopsy Forceps Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-24: Biopsy Forceps Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-25: Biopsy Forceps Procedures by Country, Middle East, 2022 - 2032
• Figure 8-26: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-27: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-28: Biopsy Forceps Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-29: Biopsy Forceps Procedures by Country, Africa, 2022 - 2032
• Figure 8-30: Polypectomy Snare Procedures by Region, Global, 2022 - 2032
• Figure 8-31: Polypectomy Snare Procedures by Country, North America, 2022 - 2032
• Figure 8-32: Polypectomy Snare Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 8-33: Polypectomy Snare Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 8-34: Polypectomy Snare Procedures by Country, Western Europe, 2022 - 2032
• Figure 8-35: Polypectomy Snare Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 8-36: Polypectomy Snare Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 8-37: Polypectomy Snare Procedures by Country, Middle East, 2022 - 2032
• Figure 8-38: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 8-39: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 8-40: Polypectomy Snare Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 8-41: Polypectomy Snare Procedures by Country, Africa, 2022 - 2032
• Figure 8-42: Biopsy Forceps & Polypectomy Snares Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 8-43: Biopsy Forceps and Polypectomy Snares Market by Region, Global, 2022 - 2032 (US$M)
• Figure 8-44: Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032
• Figure 8-45: Units Sold by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032
• Figure 8-46: Average Selling Price by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032 (US$)
• Figure 8-47: Market Value by Region, Biopsy Forceps and Polypectomy Snares Market, Global, 2022 - 2032 (US$M)
• Figure 8-48: Biopsy Forceps Market, Global, 2022 - 2032
• Figure 8-49: Units Sold by Region, Biopsy Forceps Market, Global, 2022 - 2032
• Figure 8-50: Average Selling Price by Region, Biopsy Forceps Market, Global, 2022 - 2032 (US$)
• Figure 8-51: Market Value by Region, Biopsy Forceps Market, Global, 2022 - 2032 (US$M)
• Figure 8-52: Polypectomy Snare Market, Global, 2022 - 2032
• Figure 8-53: Units Sold by Region, Polypectomy Snare Market, Global, 2022 - 2032
• Figure 8-54: Average Selling Price by Region, Polypectomy Snare Market, Global, 2022 - 2032 (US$)
• Figure 8-55: Market Value by Region, Polypectomy Snare Market, Global, 2022 - 2032 (US$M)
• Figure 8-56: Leading Competitors, Biopsy Forceps & Polypectomy Snares Market, Global, 2025